Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,257,087 papers from all fields of science
Search
Sign In
Create Free Account
auristatin PE
Known as:
N(2)-(N,N-dimethyl-valyl)-N-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenylethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-N-methyl-valinamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Narrower (1)
soblidotin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 3703: Superior efficacy of novel albumin-binding auristatin E-based prodrugs compared to auristatin E in a panel of human xenograft models in mice
Stephan David Koester
,
L. Pes
,
+9 authors
F. Kratz
Cancer Chemistry
2018
Corpus ID: 80940334
Auristatins are highly cytotoxic antimitotic tubulin-binding peptides. Of this family, only Adcetris®, an antibody drug conjugate…
Expand
2005
2005
Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors
M. D. de Jonge
,
A. van der Gaast
,
+6 authors
J. Verweij
Clinical Cancer Research
2005
Corpus ID: 36205797
Purpose: TZT-1027 {N2-(N,N-dimethyl-l-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl…
Expand
2001
2001
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model
R. Mohammad
,
N. Adsay
,
P. Philip
,
G. Pettit
,
V. Vaitkevicius
,
F. Sarkar
Anti-Cancer Drugs
2001
Corpus ID: 35257788
Pancreatic cancer has the worst prognosis of all cancers with a dismal 5-year survival rate. Hence, there is a tremendous need…
Expand
1999
1999
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.
R. Mohammad
,
C. Limvarapuss
,
+4 authors
A. Al-Katib
International Journal of Oncology
1999
Corpus ID: 26822284
Waldenstrom's macroglobulinemia (WM) is an uncommon lymphoproliferative disease which remains incurable with current treatment…
Expand
1999
1999
Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
N. Wall
,
R. Mohammad
,
S. Nabha
,
G. Pettit
,
A. Al-Katib
Biochemical and Biophysical Research…
1999
Corpus ID: 23841924
Previous studies have shown that bryostatin 1 induces a decrease in the expression of the antiapoptotic protooncogene Bcl-2 in…
Expand
1998
1998
Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
R. Mohammad
,
M. Varterasian
,
V. P. Almatchy
,
G. N. Hannoudi
,
G. Pettit
,
A. Al-Katib
Clinical Cancer Research
1998
Corpus ID: 22102314
We tested the activity of dolastatin 10 (a natural product derived from the shell-less marine mollusk, Dolabella auricularia, a…
Expand
Highly Cited
1995
Highly Cited
1995
Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
G. Pettit
,
J. Srirangam
,
+7 authors
J. Chapuis
Anti-Cancer Drug Design
1995
Corpus ID: 35508610
New structural modifications of the marine shell-less mollusk peptide constituent dolastatin 10 (1) have been synthesized, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE